Large-scale clinico-genomic profile of non-small cell lung cancer with KRAS G12C: Results from LC-SCRUM-Asia study-Reference-Cited by-同舟云学术

Large-scale clinico-genomic profile of non-small cell lung cancer with KRAS G12C: Results from LC-SCRUM-Asia study

Published:2023-02 Issue: Volume:176 Page:103-111
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Tamiya Yutaro,Matsumoto Shingo,Zenke Yoshitaka,Yoh Kiyotaka,Ikeda Takaya,Shibata Yuji,Kato Terufumi,Nishino Kazumi,Nakamura Atsushi,Furuya Naoki,Miyamoto Shingo,Kuyama Shoichi,Nomura Shogo,Ikeno Takashi,Udagawa Hibiki,Sugiyama Eri,Nosaki Kaname,Izumi Hiroki,Sakai Tetsuya,Hashimoto Naozumi,Goto Koichi

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference27 articles.

1. Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315);Griesinger;Lung Cancer,2021

2. Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT);Barlesi;Lancet,2016

3. Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy?;Roberts;J. Clin. Oncol.,2010

4. Distribution of KRASG12C somatic mutations across race, sex and cancer type;Nassar;N. Engl. J. Med.,2021

5. Sotorasib for lung cancers with KRAS p. G12C mutation;Skoulidis;N. Engl. J. Med.,2021

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?;Lung Cancer;2024-08

2. Efficacy of first‐line immune checkpoint inhibitor and anti‐angiogenic agent combination therapy for Kirsten rat sarcoma viral antigen‐mutant advanced non‐small‐cell lung cancer: a systematic review and network meta‐analysis;Thoracic Cancer;2024-07-31

3. Clinicopathologic features, concurrent genomic alterations, and clinical outcomes of patients with KRAS G12D mutations in resected lung adenocarcinoma;European Journal of Cancer;2024-05

4. Utility of bronchoscopically obtained frozen cytology pellets for next-generation sequencing;BMC Cancer;2024-04-17

5. AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells;Cancer Letters;2024-04